IBDEI137 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18150,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,18150,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,18151,0)
 ;;=B35.6^^94^905^281
 ;;^UTILITY(U,$J,358.3,18151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18151,1,3,0)
 ;;=3^Tinea Cruris
 ;;^UTILITY(U,$J,358.3,18151,1,4,0)
 ;;=4^B35.6
 ;;^UTILITY(U,$J,358.3,18151,2)
 ;;=^119711
 ;;^UTILITY(U,$J,358.3,18152,0)
 ;;=B35.3^^94^905^283
 ;;^UTILITY(U,$J,358.3,18152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18152,1,3,0)
 ;;=3^Tinea Pedis
 ;;^UTILITY(U,$J,358.3,18152,1,4,0)
 ;;=4^B35.3
 ;;^UTILITY(U,$J,358.3,18152,2)
 ;;=^119732
 ;;^UTILITY(U,$J,358.3,18153,0)
 ;;=B35.5^^94^905^282
 ;;^UTILITY(U,$J,358.3,18153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18153,1,3,0)
 ;;=3^Tinea Imbricata
 ;;^UTILITY(U,$J,358.3,18153,1,4,0)
 ;;=4^B35.5
 ;;^UTILITY(U,$J,358.3,18153,2)
 ;;=^119725
 ;;^UTILITY(U,$J,358.3,18154,0)
 ;;=B35.4^^94^905^280
 ;;^UTILITY(U,$J,358.3,18154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18154,1,3,0)
 ;;=3^Tinea Corporis
 ;;^UTILITY(U,$J,358.3,18154,1,4,0)
 ;;=4^B35.4
 ;;^UTILITY(U,$J,358.3,18154,2)
 ;;=^119704
 ;;^UTILITY(U,$J,358.3,18155,0)
 ;;=B35.8^^94^905^137
 ;;^UTILITY(U,$J,358.3,18155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18155,1,3,0)
 ;;=3^Dermatophytoses,Other
 ;;^UTILITY(U,$J,358.3,18155,1,4,0)
 ;;=4^B35.8
 ;;^UTILITY(U,$J,358.3,18155,2)
 ;;=^5000606
 ;;^UTILITY(U,$J,358.3,18156,0)
 ;;=B36.9^^94^905^272
 ;;^UTILITY(U,$J,358.3,18156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18156,1,3,0)
 ;;=3^Superficial Mycosis,Unspec
 ;;^UTILITY(U,$J,358.3,18156,1,4,0)
 ;;=4^B36.9
 ;;^UTILITY(U,$J,358.3,18156,2)
 ;;=^5000611
 ;;^UTILITY(U,$J,358.3,18157,0)
 ;;=D69.0^^94^905^32
 ;;^UTILITY(U,$J,358.3,18157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18157,1,3,0)
 ;;=3^Allergic Purpura
 ;;^UTILITY(U,$J,358.3,18157,1,4,0)
 ;;=4^D69.0
 ;;^UTILITY(U,$J,358.3,18157,2)
 ;;=^5002365
 ;;^UTILITY(U,$J,358.3,18158,0)
 ;;=B00.9^^94^905^158
 ;;^UTILITY(U,$J,358.3,18158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18158,1,3,0)
 ;;=3^Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,18158,1,4,0)
 ;;=4^B00.9
 ;;^UTILITY(U,$J,358.3,18158,2)
 ;;=^5000480
 ;;^UTILITY(U,$J,358.3,18159,0)
 ;;=B02.9^^94^905^291
 ;;^UTILITY(U,$J,358.3,18159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18159,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,18159,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,18159,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,18160,0)
 ;;=D17.9^^94^905^89
 ;;^UTILITY(U,$J,358.3,18160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18160,1,3,0)
 ;;=3^Benign Lipomatous Neop,Unspec
 ;;^UTILITY(U,$J,358.3,18160,1,4,0)
 ;;=4^D17.9
 ;;^UTILITY(U,$J,358.3,18160,2)
 ;;=^5002020
 ;;^UTILITY(U,$J,358.3,18161,0)
 ;;=E08.621^^94^905^134
 ;;^UTILITY(U,$J,358.3,18161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18161,1,3,0)
 ;;=3^DM d/t Underlying Condition w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,18161,1,4,0)
 ;;=4^E08.621
 ;;^UTILITY(U,$J,358.3,18161,2)
 ;;=^5002534
 ;;^UTILITY(U,$J,358.3,18162,0)
 ;;=E09.621^^94^905^133
 ;;^UTILITY(U,$J,358.3,18162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18162,1,3,0)
 ;;=3^DM d/t Drug/Chemical w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,18162,1,4,0)
 ;;=4^E09.621
 ;;^UTILITY(U,$J,358.3,18162,2)
 ;;=^5002576
 ;;^UTILITY(U,$J,358.3,18163,0)
 ;;=H05.011^^94^905^110
 ;;^UTILITY(U,$J,358.3,18163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18163,1,3,0)
 ;;=3^Cellulitis of Right Orbit
 ;;^UTILITY(U,$J,358.3,18163,1,4,0)
 ;;=4^H05.011
 ;;^UTILITY(U,$J,358.3,18163,2)
 ;;=^5004560
 ;;^UTILITY(U,$J,358.3,18164,0)
 ;;=H05.012^^94^905^103
